S Tomasello - Diabetes Spectrum, 2008 - Am Diabetes Assoc Secondary hyperparathyroidism (SHPT) describes a complex alteration in bone and
mineral metabolism that occurs as a direct result of chronic kidney disease
(CKD). Bone disease, a well-recognized complication of SHPT, represents ... Related articles - BL Direct - All 2 versions
TB Drüeke - Current opinion in nephrology and hypertension, 2005 - journals.lww.com Purpose of review: It is possible to control the secondary hyperparathyroidism
and osteitis fibrosa of patients with chronic kidney disease by calcitriol when
given early and in appropriate doses. However, this control is often ... Cited by 8 - Related articles - All 7 versions
GR Bailie, SG Massry - Pharmacotherapy, 2005 - PPI George R. Bailie, Pharm.D., Ph.D., FCCP, and Shaul G. Massry, MD ... The
National Kidney Foundation developed and oversees the Kidney Disease Outcomes
Quality Initiative, a process that develops clinical practice guidelines in ... Cited by 8 - Related articles - BL Direct - All 9 versions
LD QUARLES - Kidney International, 2005 - nature.com The calcium sensing receptor (CASR) is the most important factor regulating
parathyroid gland function, and allosteric modulators of CASR, called
calcimimetics, provide a novel drug therapy to suppress PTH secretion. The ... Cited by 11 - Related articles - All 3 versions
ELIA FRIEDMAN - Kidney International, 2005 - nature.com Consequences and management of hyperphosphatemia in patients with renal
insufficiency. Progressive renal insufficiency leads to hyperphosphatemia,
hypocalcemia, and secondary hyperparathyroidism. Bone demineralization in ... Cited by 12 - Related articles - All 3 versions
JD Hernandez, K Wesseling, IB Salusky - Seminars in Dialysis, 2005 - interscience.wiley.com Renal osteodystrophy (ROD) represents a spectrum of bone lesions ranging from a
high-turnover to a low-turnover state. The expression of the histologic bone
lesions is modulated by parathyroid hormone (PTH), vitamin D, calcium, ... Cited by 13 - Related articles - BL Direct - All 3 versions
MS Joy, AV Kshirsagar, N Franceschini - The Annals of pharmacotherapy, 2004 - Harvey Whitney Books DATA SOURCES: A MEDLINE search (1990–April 2004) was performed to identify all
published articles related to calcimimetics. Published abstracts over the
previous 5 years from various scientific meetings (American Society of ... Cited by 14 - Related articles - BL Direct - All 4 versions
I Shahapuni, J Mansour, L Harbouche, B … - Semin Dial, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 15 - Related articles - All 3 versions
RA DELLA SARDEGNA - regionesardegna.it 12g/die ) per garantire un adeguato controllo della fosfatemia. La
somministrazione della vit. D aveva lo scopo di aumentare la calcemia e curare
l'IPS. Successivamente, dopo la dimostrazione del suo ruolo Related articles - View as HTML - All 3 versions
